Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings

被引:67
作者
Barrett, Jeffrey S. [1 ,2 ]
Fossler, Michael J. [3 ]
Cadieu, K. David
Gastonguay, Marc R. [4 ]
机构
[1] Childrens Hosp Philadelphia, Lab Appl PK PD, Clin Pharmacol & Therapeut Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Abramson Res Ctr, Philadelphia, PA 19104 USA
[3] GlaxoSmithKline, Dept Clin Pharmcokinet Modeling & Simulat, King Of Prussia, PA USA
[4] KDC Grp Inc, Lawrenceville, NJ USA
关键词
pharmacometrics; critical path; NIH roadmap; education; clinical pharmacology;
D O I
10.1177/0091270008315318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacometrics has evolved beyond quantitative analysis methods used to facilitate decision making in drug development, although the application of the discipline in this arena continues to represent the primary emphasis of scientists calling themselves pharmacometricians. While related fields populate and interface with pharmacometrics, there is a natural synergy with clinical pharmacology due to common areas of research and the decision-making expectation with respect to evolving conventional and translational research paradigms. Innovative and adaptable training programs and resources are essential in this regard as both disciplines promise to be key elements of the clinical research workplace of the future. The demand for scientists with pharmacometrics skills has risen substantially. Likewise, the salary garnered by those with these skills appears to be surpassing their counterparts without such backgrounds. Given the paucity of existing training programs, available training materials, and academic champions, a virtual faculty and online curriculum would allow students to matriculate into one of several programs associated with their advisor but take instruction from faculty at multiple institutions, including instructors in both industrial and regulatory settings. Flexibility in both the curriculum and the governance of the degree would provide the greatest hope of addressing the short supply of trained pharmacometricians.
引用
收藏
页码:632 / 649
页数:18
相关论文
共 44 条
[1]   Comparison of rheumatoid arthritis clinical trial outcome measures - A simulation study [J].
Anderson, JJ ;
Bolognese, JA ;
Felson, DT .
ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3031-3038
[2]   Introduction of quantitative methods in pharmacology and clinical pharmacology: A historical overview [J].
Atkinson, A. J., Jr. ;
Lalonde, R. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (01) :3-6
[3]  
Barnett Joey, 2006, Mol Interv, V6, P4, DOI 10.1124/mi.6.1.1
[4]   Facilitating compound progression of Antiretroviral agents via Modeling and simulation [J].
Barrett, Jeffrey S. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2007, 2 (01) :58-71
[5]  
BARRETT JS, IN PRESS AAPS J
[6]  
Barton P, 2004, HEALTH TECHNOL ASSES, V8, P1
[7]   Impact of pharmacometric reviews on new drug approval and labeling decisions - a survey of 31 new drug applications submitted between 2005 and 2006 [J].
Bhattaram, V. A. ;
Bonapace, C. ;
Chilukuri, D. M. ;
Duan, J. Z. ;
Garnett, C. ;
Gobburu, J. V. S. ;
Jang, S. H. ;
Kenna, L. ;
Lesko, L. J. ;
Madabushi, R. ;
Men, Y. ;
Powell, J. R. ;
Qiu, W. ;
Ramchandani, R. P. ;
Tornoe, C. W. ;
Wang, Y. ;
Zheng, J. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :213-221
[8]   Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications [J].
Bhattaram, VA ;
Booth, BP ;
Ramchandani, RP ;
Beasley, BN ;
Wang, YN ;
Tandon, V ;
Duan, JZ ;
Baweja, RK ;
Marroum, PJ ;
Uppoor, RS ;
Rahman, NA ;
Sahajwalla, CG ;
Powell, JR ;
Mehta, MU ;
Gobburu, JVS .
AAPS JOURNAL, 2005, 7 (03) :E503-E512
[9]  
Bonate P.L., 2006, PHARMACOKINETIC PHAR
[10]   Model selection and mixed-effects modeling of HIV infection dynamics [J].
Bortz, D. M. ;
Nelson, P. W. .
BULLETIN OF MATHEMATICAL BIOLOGY, 2006, 68 (08) :2005-2025